Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
Mary Anne Heino
|
| gptkbp:formerName |
Lantheus Medical Imaging, Inc.
|
| gptkbp:founded |
1956
|
| gptkbp:headquarters_location |
gptkb:North_Billerica,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lantheus Holdings
|
| gptkbp:industry |
pharmaceuticals
medical imaging |
| gptkbp:ISIN |
US5165441032
|
| gptkbp:notableProduct |
DEFINITY
Pylarify TechneLite |
| gptkbp:numberOfEmployees |
approximately 600
|
| gptkbp:products |
contrast agents
radiopharmaceuticals diagnostic imaging agents |
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
LNTH
|
| gptkbp:website |
https://www.lantheus.com/
|
| gptkbp:bfsParent |
gptkb:Progenics_Pharmaceuticals
gptkb:Avista_Capital_Partners |
| gptkbp:bfsLayer |
7
|